Is VivoSim Labs, INC. (VIVS) Halal?
Shariah Screening — 5 Standards
Based on financial data from March 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 19.7% / 30% | 237.0% / 30% | 0.6% / 30% | 97.22% / 5% | ✗ NOT HALAL |
| DJIM | 19.7% / 33% | 237.0% / 33% | 0.6% / 33% | 97.22% / 5% | ✗ NOT HALAL |
| MSCI | 6.4% / 33% | 77.2% / 33% | 0.2% / 33% | 97.22% / 5% | ✗ NOT HALAL |
| S&P | 19.7% / 33% | 237.0% / 33% | 0.6% / 33% | 97.22% / 5% | ✗ NOT HALAL |
| FTSE | 6.4% / 33% | 77.2% / 33% | 0.2% / 50% | 97.22% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 0.0% | |
| Operating Margin | -10576.9% | |
| Net Margin | 0.0% | |
| Return on Equity (ROE) | -51.1% | |
| Return on Assets (ROA) | -132.5% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$9M |
| Free Cash Flow | -$9M |
| Total Debt | $942,000 |
| Debt-to-Equity | 18.3 |
| Current Ratio | 2.4 |
| Total Assets | $15M |
Price & Trading
| Last Close | $1.69 |
| 50-Day MA | $1.97 |
| 200-Day MA | $2.20 |
| Avg Volume | 1.7M |
| Beta | 1.3 |
|
52-Week Range
$1.41
| |
About VivoSim Labs, INC. (VIVS)
VivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. It offers partners liver and intestinal toxicology insights through its new approach methodologies (NAM) models; and bespoke services in the areas of investigational toxicology, mechanism of drug action elucidation, and other applications of complex human tissue models. The company also provides liver toxicology predictive screening and research services, as well as works on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at various stages of drug development; and uses its proprietary technologies to build functional 3D human tissues that mimic key aspects of native human tissue composition, architecture, function, and disease. In addition, it offers 3D human tissue platform that develops novel human normal and disease models using high throughput systems, bioprinted, and flow/stretch capable 3D systems. The company was formerly known as Organovo Holdings, Inc. and changed its name to VivoSim Labs, Inc. in April 2025. VivoSim Labs, Inc. was incorporated in 2007 and is headquartered in San Diego, California.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is VivoSim Labs, INC. (VIVS) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), VivoSim Labs, INC. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is VivoSim Labs, INC.'s debt ratio?
VivoSim Labs, INC.'s debt ratio is 19.7% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 6.4%.
What are VivoSim Labs, INC.'s key financial metrics?
VivoSim Labs, INC. has a market capitalization of $4M, trailing P/E ratio of 0.9, and revenue of $144,000. Return on equity stands at -51.1%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.